Lancemaside A, a major triterpene saponin of Codonopsis lanceolata enhances regulation of nitric oxide synthesis via eNOS activation
Open Access
- 24 May 2019
- journal article
- research article
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 19 (1) , 110
Abstract
Many studies on the effect of saponin-rich Codonopsis lanceolata as a bioactive source for improving physical health have been performed. C. lanceolata contains triterpenoid saponins, including lancemasides. These saponins are known to be particularly involved in the regulation of blood pressure or hypertension. This study investigated whether lancemaside A (LA), a major triterpenoid saponin from C. lanceolata, regulates nitric oxide (NO) production via the activation of endothelial NO synthase (eNOS) in human umbilical vein endothelial cells. Upon separation with petroleum ether, ethyl acetate, and n-butanol, LA was found to be abundant in the n-butanol-soluble portion. For further purification of LA, HPLC was performed to collect fraction, and LA was identified using analysis of LC/MSMS and 13C-NMR values. In in vitro, the effects of LA on NO release mechanism in HUVECs were investigated by Griess assay, quantitative real-time reverse-transcription PCR, and Western blotting. Our results showed that NO production was efficiently improved by treatment with LA in a dose-dependent manner. In addition, the LA treatment resulted in extensive recovery of the NO production suppressed by the eNOS inhibitor, L-NAME, compared with that in the control group. Additionally, the level of eNOS mRNA was increased by this treatment in a dose-dependent manner. These results suggested that LA is an inducer of NO synthesis via eNOS mRNA expression. Also, the study indicated that LA is involved in activating the PI3K/Akt/eNOS signaling pathway. These results suggested that LA is an inducer of NO synthesis via eNOS mRNA expression. Also, the study indicated that LA is involved in activating the PI3K/Akt/eNOS signaling pathway. These findings suggest the value of using LA as a component of functional foods and natural pharmaceuticals.Keywords
Funding Information
- National Assembly (R1605812)
This publication has 42 references indexed in Scilit:
- Lancemaside A inhibits microglial activation via modulation of JNK signaling pathwayBiochemical and Biophysical Research Communications, 2013
- Antiobesity Effect ofCodonopsis lanceolatain High-Calorie/High-Fat-Diet-Induced Obese RatsEvidence-Based Complementary and Alternative Medicine, 2013
- Ginsenoside Rb1 Reverses H2O2-induced Senescence in Human Umbilical Endothelial CellsJournal of Cardiovascular Pharmacology, 2012
- Panax notoginseng and its components decreased hypertension via stimulation of endothelial-dependent vessel dilatationVascular Pharmacology, 2012
- Akt/eNOS pathway activation in endothelium-dependent relaxation is preserved in aortas from female, but not from male, type 2 diabetic micePharmacological Research, 2012
- Reduction of Blood Pressure by Soybean Saponins, Renin Inhibitors from Soybean, in Spontaneously Hypertensive RatsBioscience, Biotechnology, and Biochemistry, 2010
- Role of FAK phosphorylation in hypoxia-induced hMSCS migration: involvement of VEGF as well as MAPKS and eNOS pathwaysAmerican Journal of Physiology-Cell Physiology, 2010
- Endogenous Nitric Oxide Protects Bacteria Against a Wide Spectrum of AntibioticsScience, 2009
- Signaling pathway of ginsenoside‐Rg1 leading to nitric oxide production in endothelial cellsFEBS Letters, 2006
- Endothelial Nitric Oxide Synthase in Vascular DiseaseCirculation, 2006